Curtis A Blow,Luke A Probst,Christopher D Miller et al.
Curtis A Blow et al.
Andexanet Alfa (Andexxa®) for the Reversal of Direct Oral Anticoagulants [0.03%]
安达赛特（ANDXAA）用于直接口服抗凝剂的解救治疗
Jayed H Momin,PharmD Candidate,Gregory J Hughes
Jayed H Momin
Andexanet alfa (Andexxa®) for the reversal of direct oral anticoagulants. Keywords: Andexxa; andexanet alfa...
Pharmaceutical Approval Update [0.03%]
药品审批更新
Mary Choy
Mary Choy
Alpelisib (Piqray) for HR-positive/HER2-negative, PIK3CA-mutated, advanced/ metastatic breast cancer; polatuzumab vedotin-piiq (Polivy) for diffuse large B-cell lymphoma; and eculizumab (Soliris) for neuromyelitis optica spectrum disorder.
Drug and Device News [0.03%]
药讯医疗器械讯
Approvals, new indications and formulations, and safety issues.
Bipartisan Drug-Patent Bills Ready for Senate Vote: Efforts Directed at Speeding Up Introduction of Generics [0.03%]
参议院准备就两党药物专利法案进行投票审议
Stephen Barlas
Stephen Barlas
The legal tactics that drug manufacturers use to extend drug patents may be the biggest impediment to lowering drug prices and to Congress acting on pricing. Until now, that is.
Hardwiring Safety Into the Computer System: One Hospital's Actions to Provide Technology Support for U-500 Insulin [0.03%]
将安全功能整合进计算机系统：一家医院采用技术手段支持U-500胰岛素注射的安全实践
Matthew Grissinger
Matthew Grissinger
We present technology enhancements that support the safe use of U-500 insulin.
John Otrompke
John Otrompke
Walter Alexander
Walter Alexander